This study will compare the clinical outcomes for patients undergoing a total knee replacement using a bipolar sealer, the Aquamantys® System, as compared to standard electrocautery. Total blood loss...

Condition : Osteoarthritis Interventions : Drug: GA-arm, remifentanil; Drug: placebo Sponsor : Region Skane Recruiting - verified November 2013

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Active, not recruiting - verified February 2014

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Active, not recruiting - verified November 2013

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Active, not recruiting - verified September 2013

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Active, not recruiting - verified February 2014

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Active, not recruiting - verified November 2013

Condition : Juvenile Idiopathic Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Active, not recruiting - verified February 2014

Condition : Juvenile Idiopathic Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Recruiting - verified November 2013

Condition : Juvenile Idiopathic Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Recruiting - verified September 2013